Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Oxytocin for Weight Loss in Hypothalamic Obesity
NCT02849743Phase 2Completed
- Start
- Oct 2016
- Primary completion
- Apr 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin in hypothalamic obesity (HO). Started Oct 2016; status: completed.
02
Drugs
oxytocin
03
Conditions
hypothalamic obesity (HO)
Beyond the preview
Go deeper on NCT02849743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02849743.